Asthma Resources
Midwest Allergy Sinus Asthma, SCAsthma is a chronic disease that affects the inside walls of your airways, making them sore and swollen. This makes them quite sensitive, and they might react strongly to particles that you are allergic to or find irritating. When your airways react to these things, they get narrower, causing your lungs to get less air. When this reaction becomes much worse than usual, it’s called an asthma attack. Severe attacks may require immediate medical attention can be fatal if left untreated.
Symptoms can include, but are not limited to, wheezing, excessive coughing, tightening of the chest, and shortness of breath.
Related Articles:
Clinical Trial: Asthma Study 2024-2027 (12-17 years old)
Join a clinical study evaluating asthma treatments for teens aged 12-17. This 24-week study provides medication and care at no cost, with compensation for time and travel. Contact us to see if your teen qualifies!
Access to Epipen and Inhalers: Public Acts for Central Illinois Schools
Recent public acts in Central Illinois empower schools to improve student safety by providing resources for asthma and allergy management and enabling access to Epipen and Inhaler. This page unifies essential links and resources and find out how MASA can help schools to create a safer learning environment for students with asthma and allergies.
What is the relationship between Eosinophilic esophagitis (EoE) and asthma?
Eosinophilic esophagitis (EoE) and asthma are both conditions characterized by eosinophilic inflammation, though they affect different parts of the body. EoE is a chronic allergic inflammatory disease of the esophagus, while asthma is a chronic inflammatory disease of...
Clinical Study: Severe Asthma NIMBLE (Continued Care) 2023 2024
Are you an adult or with a child 12 years old or above who has severe asthma?
Do you have documented physician diagnosis of asthma for 2 years or more?
We accept participants of all sexes.
You may be eligible for a study with compensation for time and travel up to $2000.